Quest diagnostics says received eua from u.s. fda to use specimen pooling with its proprietary molecular diagnostic test for covid-19

Received eua from fda to use specimen pooling with its proprietary molecular diagnostic test for covid-19.quest diagnostics -expects to deploy technique at its labs in chantilly, va and marlborough, mass., by end of next week with additional labs to follow.
DGX Ratings Summary
DGX Quant Ranking